BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2008
View Archived Issues
Addition of saxagliptin to a sulfonylurea or thiazolidinedione improves glucose control
Read More
Sucrose octasulphate demonstrates oral antirheumatic activity
Read More
Galectin-3 as potential therapeutic target in post-ischemic functional recovery
Read More
New treatment option for Wilson's disease disclosed in recent SSV patent
Read More
Novel treatments for endocrine-associated disorders imparted in recent patents
Read More
Recent GSK patent describes new analgesic agents
Read More
MediGene spins out mTCR technology platform to newly founded Immunocore
Read More
PharmAthene enters into strategic alliance with Panacea Biotec
Read More
OrthoLogic changes trade name to Capstone Therapeutics
Read More
Kringle files IND with FDA for phase I clinical trial of recombinant human HGF in renal disease
Read More
Affymetrix and MPI sign agreement for Affymetrix microarray technology in cancer
Read More
pSivida reports 6-month interim readout of the human PK Iluvien study
Read More
TorreyPines reports successful end-of-phase II meeting with FDA for tezampanel
Read More
Exelixis files IND with the FDA for XL-888
Read More
Ironwood raises USD 50 million for linaclotide phase III development program
Read More
Aeolus receives milestone payment from ARCA following acceptance of bucindolol NDA
Read More
PPD acquires InnoPharm
Read More
RegeneRx seeks strategic partner to develop RGN-457 for cystic fibrosis
Read More
Meda and Recordati sign long-term agreement for Lercadip in Spain
Read More
Mentor reports positive results from phase III clinical trial of PurTox in glabellar rhytides
Read More
Emergent signs new contract with HHS to supply anthrax vaccine BioThrax for SNS
Read More
Dara completes toxicology studies neeeded for phase I trials of DB-959, gives pipeline update
Read More
Daiichi Sankyo and Kuhnil initiate enrollment in phase II trial of nimotuzumab in gastric cancer
Read More
Kyowa Hakko Kogyo and Kirin Pharma complete business merger
Read More
Toctino receives marketing authorization in Germany
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Enobia Pharma
Read More
Interim analysis of phase II sorafenib study shows safety and activity against thyroid cancer
Read More